DrFirst Healthcare Technology Blog

I-STOP in New York is Finally Taking Off

March 27, 2014

In the very short amount of time since the New York State Bureau of Narcotics Enforcement (BNE) finalized its guidelines for providers and pharmacies to implement the Internet System for Tracking Over-Prescribing (I-STOP) there has been a widespread movement from the New York healthcare community to begin using the new technology. As of this writing, there are currently 1,346 pharmacies across the state that accept electronic transmissions of controlled substance prescriptions. Rite Aid was the first of the large pharmacy chains to become enabled in New York, followed quickly by Duane Reade and Walgreens. As of the publication time for this blog, CVS also has plans in motion that will bring its pharmacies across New York into the network of controlled substance e-prescription-enabled pharmacies within the next six months.

In essence, after a long runway, I-STOP is finally taking off.

New York providers have until March 27, 2015 to comply with the mandate to e-prescribe. But what, exactly, does that mean? First, providers need to identify an e-prescribing option that includes controlled substances well in advance of the deadline in order to complete the identity proofing (IDP) process. Providers must follow all of the requirements established by the United State Drug Enforcement Administration (DEA) in its Interim Final Rule regarding Electronic Prescriptions of Controlled Substances (information about these requirements can be found here, on the DEA website). In addition to following federal regulations, New York providers must also submit registration materials to New York’s Department of Health, Bureau of Narcotic Enforcement. More information about this process can be found on the BNE website, and a complete list of New York State requirements for EPCS can also be found here.

In short here are the 3 things a provider needs to do:

  1. Contract with e-prescribing company that is approved for controlled substance prescribing
  2. Complete the identity-proofing process and receive your token
  3. Complete the New York BNE registration form, sign it, scan it and email to narcotic@health.state.ny.us

Proponents of controlled substance e-prescribing are highly encouraged by I-STOP and applaud New York for leveraging technology to help combat the continued diversion and abuse of controlled substances. DrFirst in particular is proud of its history as the pioneering leader of this emerging technology that started with our helping the DEA shape its interim final rule requirements, continued when a DrFirst prescriber sent the very first electronic prescription for a controlled substance in Berkshire County, Massachusetts in 2009. DrFirst has long recognized the amazing potential which controlled substance e-prescribing has in the fight to keep the controlled drug abuse pandemic at bay.

Return to Posts

About the Author

Michelle Soble-Lernor

Michelle Soble-Lernor is DrFirst’s Principle Pharmacist, and works in our Clinical Quality Office. Michelle plays a leading role in ensuring the security, quality, and precision of DrFirst’s interactions with key stakeholders. She earned her BA in Pharmacy and her Master’s in Toxicology at the University of Arizona prior to receiving her MBA in Healthcare Management at Western International University. In addition to her duties at DrFirst, Ms. Soble-Lernor is also an active and influential voice within her pharmacy community, serving as a Clinical Instructor of Pharmacy Practice and Services for the University of Arizona’s pharmacy school, as well as an Adjunct Assistant Professor of Pharmacy Practice at Midwestern University Glendale’s pharmacy school. Ms. Soble-Lernor also continues to work as a retail pharmacist on a limited basis in order to stay abreast of new industry trends and dynamics.